The Effects of Nanotechnology on Drug Delivery Systems in Cancer Treatment

Abstract

Nanotechnology has emerged as a transformative tool in the field of drug delivery systems (DDS), particularly in the treatment of cancer. The ability of nanomaterials to manipulate drug release, enhance targeted delivery, and improve the bioavailability of therapeutic agents has made them promising candidates for improving cancer treatment outcomes. This paper discusses the principles behind nanotechnology-based drug delivery systems, their role in overcoming the limitations of traditional cancer therapies, and the latest advancements in this field. Various nanocarriers, such as liposomes, dendrimers, and nanoparticles, are examined for their effectiveness in increasing the specificity of drug targeting, minimizing side effects, and enhancing therapeutic efficacy. Furthermore, the challenges and future directions of nanotechnology in cancer drug delivery are explored.